PYC — PYC Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$1.43bn
- AU$1.31bn
- AU$26.17m
Brief: PYC Therapeutics Says HY Revenues From Ordinary Activities Up 162% To A$9.1 Million
Australia's PYC Therapeutics jumps on positive results from PKD drug study
Brief: PYC Therapeutics Holds Pre-IND Meeting With US FDA
Brief: PYC Therapeutics Says Safety Review Committee Approves Dose Escalation To Patient Cohort
Brief: PYC Therapeutics Says FY Income From Ordinary Activities Down 1.0%
Brief: US FDA Designates PYC's Lead As Fast Track Development Program
Brief: PYC Therapeutics Increases Shareholding In Vision Pharma To 96.2%
PYC Therapeutics jumps after U.S. FDA fast-track nod for eye disease drug
Brief: Pyc Therapeutics Says VP-001 Program, Got Fast Track Designation From US FDA
Brief: PYC Therapeutics Announces Completion Of A$30 Million Placement
Brief: PYC Therapeutics Seeks Trading Halt
Australia's PYC Therapeutics rises on regulator nod for Phase I study
Australia's PYC Therapeutics surges on eye-treatment drugs progress
Australia's PYC Therapeutics jumps most in about 11 mths on FDA clearance
Brief: PYC Therapeutics Says U.S. FDA Clears Co To Start Human Trial In Retinitis Pigmentosa Type 11
Brief: Pyc Therapeutics Ltd Seeks Trading Halt
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities Of A$3.5 Million
Brief: PYC Therapeutics Says Submitted IND Application With U.S. FDA For VP-001
Brief: Pyc Therapeutics Says Has Increased Its Shareholding In Vision Pharma